AI Proteins

Healthcare AI drug discovery / protein therapeutics Series A

AI Proteins is a Boston-based biotechnology company focused on designing de novo miniprotein therapeutics using AI-enabled protein design and a high-throughput discovery platform. The company says it creates synthetic proteins from first principles for therapeutic applications, with a pipeline spanning multiple targets and a focus on areas such as inflammation, metabolic disease, and oncology.